IP Forecast: Fed. Circ. To Mull Arthrex's Latest USPTO Fight

By Andrew Karpan · March 24, 2022, 9:05 PM EDT

Arthrex will argue next week that the Federal Circuit must undo the Patent Trial and Appeal Board's invalidation of its suture patent because the patent office's interim leader lacks the power...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.

Case Number

1:18-cv-00651

Court

Delaware

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

April 30, 2018

Case Title

Arthrex, Inc. v. Smith & Nephew, Inc.

Case Number

18-2140

Court

Appellate - Federal Circuit

Nature of Suit

- 

Date Filed

July 09, 2018

Case Title

MicroSource, LLC et al v. Eco World Group, LLC et al

Case Number

5:19-cv-04016

Court

Iowa Northern

Nature of Suit

Patent

Date Filed

April 18, 2019

Case Title

PureWick Corporation v. Sage Products, LLC

Case Number

1:19-cv-01508

Court

Delaware

Nature of Suit

Patent

Date Filed

August 12, 2019

Case Title

Facebook, Inc. et al v. OnLineNic Inc et al

Case Number

3:19-cv-07071

Court

California Northern

Nature of Suit

Trademark

Date Filed

October 28, 2019

Case Title

The United States of America v. Gilead Sciences, Inc. et al

Case Number

1:19-cv-02103

Court

Delaware

Nature of Suit

Patent

Date Filed

November 06, 2019

Case Title

IN RE: Ahern Rentals, Inc., Trade Secret Litigation

Case Number

2945

Court

Judicial Panel on Multidistrict Litigation

Nature of Suit

Date Filed

May 06, 2020

Recent Articles By Andrew